A detailed history of Brinker Capital Investments, LLC transactions in Novartis Ag stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 29,341 shares of NVS stock, worth $3.05 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
29,341
Previous 28,480 3.02%
Holding current value
$3.05 Million
Previous $2.17 Million 22.91%
% of portfolio
0.05%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$75.55 - $92.52 $65,048 - $79,659
861 Added 3.02%
29,341 $2.66 Million
Q3 2022

Nov 01, 2022

SELL
$74.61 - $87.26 $230,694 - $269,807
-3,092 Reduced 9.79%
28,480 $2.17 Million
Q2 2022

Jul 18, 2022

SELL
$80.52 - $93.75 $2.78 Million - $3.23 Million
-34,466 Reduced 52.19%
31,572 $2.67 Million
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $234,642 - $265,425
2,929 Added 4.64%
66,038 $5.8 Million
Q4 2021

Feb 08, 2022

BUY
$79.7 - $88.13 $261,256 - $288,890
3,278 Added 5.48%
63,109 $5.52 Million
Q2 2021

Aug 03, 2021

BUY
$85.24 - $94.15 $1.21 Million - $1.34 Million
14,207 Added 31.14%
59,831 $5.46 Million
Q1 2021

May 12, 2021

SELL
$83.5 - $98.47 $4.7 Million - $5.54 Million
-56,277 Reduced 55.23%
45,624 $3.91 Million
Q4 2020

Feb 16, 2021

SELL
$78.07 - $94.43 $450,620 - $545,049
-5,772 Reduced 5.36%
101,901 $9.62 Million
Q3 2020

Dec 03, 2020

BUY
$82.14 - $91.0 $8.84 Million - $9.8 Million
107,673 New
107,673 $9.38 Million
Q1 2020

May 13, 2020

SELL
$70.67 - $99.01 $28,621 - $40,099
-405 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$85.54 - $94.26 $11,633 - $12,819
-136 Reduced 25.14%
405 $35,000
Q2 2019

Aug 14, 2019

BUY
$75.4 - $92.8 $25,636 - $31,552
340 Added 169.15%
541 $49,000
Q1 2019

May 14, 2019

BUY
$75.32 - $86.15 $8,435 - $9,648
112 Added 125.84%
201 $19,000
Q3 2018

Nov 13, 2018

BUY
$66.94 - $77.43 $5,957 - $6,891
89 New
89 $8,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.